Recombinant glutathione S-transferase/CD36 fusion proteins define an oxidized low density lipoprotein-binding domain
- PMID: 9857015
- DOI: 10.1074/jbc.273.52.34875
Recombinant glutathione S-transferase/CD36 fusion proteins define an oxidized low density lipoprotein-binding domain
Abstract
CD36 is a multifunctional cell-surface receptor that binds adhesion molecules such as thrombospondin-1 and collagen and modified lipids and/or lipoproteins. It participates in cellular uptake of photoreceptor outer segments and scavenging of apoptotic cells and oxidized low density lipoprotein (Ox-LDL). Recognition and internalization of Ox-LDL by mononuclear phagocytes may play an important role in the development of atherosclerotic lesions. We have utilized a series of recombinant bacterial glutathione S-transferase/CD36 fusion proteins that span nearly all of the CD36 molecule to characterize the structural domain on CD36 that recognizes Ox-LDL. We found that the Ox-LDL-binding domain is different from the thrombospondin-1-binding domain located at amino acids 93-120. A fusion protein containing the region extending from amino acids 5 to 143 formed specific, saturable, and reversible complexes with Ox-LDL. As with intact CD36, binding was blocked by excess unlabeled Ox-LDL and antibodies to CD36. The stoichiometry and affinity of the fusion protein for Ox-LDL were similar to those of the intact protein. We also demonstrated that this fusion protein competitively inhibited binding of Ox-LDL to purified platelet CD36 and to CD36 expressed on peripheral blood monocytes and CD36 cDNA-transfected melanoma cells. The use of smaller peptides and fusion proteins including those spanning amino acids 28-93 and 5-93 has further narrowed the binding site to a region from amino acids 28 to 93, although participation of a sequence in the noncontiguous region 120-155 cannot be excluded. This study, for the first time, demonstrates unique regions of the scavenger receptor CD36 that bind the Ox-LDL ligand. Our structural analysis of the receptor provides information as to potential control of the trafficking of modified lipoproteins into the blood vessel wall.
Similar articles
-
Recombinant GST/CD36 fusion proteins define a thrombospondin binding domain. Evidence for a single calcium-dependent binding site on CD36.J Biol Chem. 1995 Feb 17;270(7):2981-6. doi: 10.1074/jbc.270.7.2981. J Biol Chem. 1995. PMID: 7531696
-
Identification on human CD36 of a domain (155-183) implicated in binding oxidized low-density lipoproteins (Ox-LDL).Arterioscler Thromb Vasc Biol. 1996 Aug;16(8):1033-9. doi: 10.1161/01.atv.16.8.1033. Arterioscler Thromb Vasc Biol. 1996. PMID: 8696943
-
Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site.Arterioscler Thromb Vasc Biol. 1995 Feb;15(2):269-75. doi: 10.1161/01.atv.15.2.269. Arterioscler Thromb Vasc Biol. 1995. PMID: 7538425
-
CD36 in Atherosclerosis: Pathophysiological Mechanisms and Therapeutic Implications.Curr Atheroscler Rep. 2020 Aug 9;22(10):59. doi: 10.1007/s11883-020-00870-8. Curr Atheroscler Rep. 2020. PMID: 32772254 Review.
-
The enigmatic membrane fatty acid transporter CD36: New insights into fatty acid binding and their effects on uptake of oxidized LDL.Prostaglandins Leukot Essent Fatty Acids. 2018 Nov;138:64-70. doi: 10.1016/j.plefa.2016.05.005. Epub 2016 May 20. Prostaglandins Leukot Essent Fatty Acids. 2018. PMID: 27288302 Review.
Cited by
-
CD36: implications in cardiovascular disease.Int J Biochem Cell Biol. 2007;39(11):2012-30. doi: 10.1016/j.biocel.2007.03.012. Epub 2007 Mar 23. Int J Biochem Cell Biol. 2007. PMID: 17466567 Free PMC article. Review.
-
Histidine-rich glycoprotein modulates the anti-angiogenic effects of vasculostatin.Am J Pathol. 2010 Apr;176(4):2039-50. doi: 10.2353/ajpath.2010.090782. Epub 2010 Feb 18. Am J Pathol. 2010. PMID: 20167858 Free PMC article.
-
CD36 signaling inhibits the translation of heat shock protein 70 induced by oxidized low density lipoprotein through activation of peroxisome proliferators-activated receptor gamma.Exp Mol Med. 2008 Dec 31;40(6):658-68. doi: 10.3858/emm.2008.40.6.658. Exp Mol Med. 2008. PMID: 19116451 Free PMC article.
-
Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism.Cancer Res. 2009 Feb 1;69(3):1212-20. doi: 10.1158/0008-5472.CAN-08-1166. Epub 2009 Jan 27. Cancer Res. 2009. PMID: 19176395 Free PMC article.
-
Identification of the growth hormone-releasing peptide binding site in CD36: a photoaffinity cross-linking study.Biochem J. 2004 Sep 1;382(Pt 2):417-24. doi: 10.1042/BJ20040036. Biochem J. 2004. PMID: 15176951 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials